Pro-Dex, Inc. (PDEX)

NASDAQ: PDEX · USD

$63.4

+1.10 (+1.8%)· Recorded snapshot

Market cap	203M
Revenue (ttm)	77.5M
Net income (ttm)	13.7M
EPS (ttm)	$4.12
Shares out	3.2M
P/E (trailing)	15.4x
P/E (forward)	20.3x
Volume	44,422
Beta	0.04

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 77.5M
Net income (ttm): 13.7M
EPS (ttm): $4.12
P/E (trailing): 15.4x
P/E (forward): 20.3x
Market cap: 203M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E20.3

P25 n/aP50 n/aP75 n/a

Trailing P/E15.4

P25 n/aP50 n/aP75 n/a

ROE32.4

P25 n/aP50 n/aP75 n/a

ROIC17.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PDEX indicators

Market & fundamental data

Available fields

269

Groups with data

Currency

USD

Showing 269 of 269 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000788920
Company name	Pro-Dex, Inc.
Country	United States
Country code	US
CUSIP number	74265M205
Earnings date	2026-11-10
Earnings time	amc
Employees	206
Employees change	25
Employees growth	13.81%
Enterprise value	$212.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	June
Founded	1978
In index	RUSSELL2000
Industry	Medical Instruments & Supplies
Is primary listing	Yes
Is SPAC	No
ISIN number	US74265M2052
Last 10-K release date	2026-09-03
Last earnings date	2026-09-03
Last refreshed	2026-10-28
Last stock split date	2010-06-18
Last stock split type	Reverse
Market cap	$203M
Market cap category	Micro-Cap
Next earnings date	2026-11-10
Options	No
Price	$63.37
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	PDEX
U.S. state	California
Website	https://www.pro-dex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	15.38x
Average P/E ratio (10Y)	14.73x
Average P/E ratio (3Y)	17.98x
Average P/E ratio (5Y)	16.01x
Earnings yield	6.5%
EV/Earnings	15.27x
EV/EBIT	16.05x
EV/EBITDA	14.5x
EV/FCF	30.86x
EV/Sales	2.69x
FCF / EV yield	3.24%
FCF yield	3.39%
Forward EV/Sales	2.53x
Forward P/E	20.34x
Forward P/S	2.41x
Graham number	37.22732
Graham upside	-40.22%
Industry forward P/E	22.69x
Industry P/E	75.18x
Lynch fair value	$71.00
Lynch upside	14.01%
P/(FCF - SBC) ratio	32.86x
P/(OCF - SBC) ratio	30.44x
P/B ratio	4.17x
P/E ratio	15.38x
P/FCF ratio	29.51x
P/OCF ratio	27.54x
P/S ratio	2.57x
Price / tangible book value	4.93x
Price/EBITDA ratio	13.87x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.75%
EBITDA margin	18.55%
Effective tax rate	24.16%
FCF margin	8.72%
Gross margin	31.38%
Operating margin	16.75%
Pretax margin	23.23%
Profit margin	17.62%
Profit per employee	$66,320
Profitable quarters	11
Profitable years	11
Revenue per employee	$376,447
ROA	11.97%
ROA (5Y)	9.36%
ROCE	21.11%
ROE	32.43%
ROE (5Y)	22.15%
ROIC	17.65%
ROIC (5Y)	15.02%
SBC / revenue	0.89%
Tax / revenue	5.61%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	54.31%
EPS growth (Q)	143.36%
EPS growth (QoQ)	-27.44%
EPS growth 10Y	35.43%
EPS growth 3Y	28.32%
EPS growth 5Y	21.28%
EPS growth quarters	4
EPS growth years	2
FCF growth 3Y	14.62%
Gross profit growth	24.73%
Gross profit growth (Q)	103.12%
Gross profit growth 3Y	24.05%
Gross profit growth 5Y	12.38%
Net income growth	52.17%
Net income growth (Q)	138.68%
Net income growth (QoQ)	-27.45%
Net income growth 3Y	24.53%
Net income growth 5Y	17.23%
Net income growth quarters	4
Net income growth years	2
OCF growth 10Y	31.57%
OCF growth 3Y	9.86%
Operating income growth	21.54%
Operating income growth (Q)	162.57%
Operating income growth 3Y	31.13%
Operating income growth 5Y	23.48%
Revenue growth	16.45%
Revenue growth (Q)	16.64%
Revenue growth (QoQ)	2.29%
Revenue growth 10Y	14.99%
Revenue growth 3Y	18.94%
Revenue growth 5Y	15.32%
Revenue growth quarters	12
Revenue growth years	12

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-483,000
Depreciation and amortization	$1.4M
EBIT	$13M
EBITDA	$14.4M
EPS	$4.12
FCF per share	$2.11
Financing cash flow	$-3.4M
Free cash flow	$6.8M
Free cash flow minus SBC	$6.1M
Gross profit	$24.3M
Income taxes	$4.4M
Investing cash flow	$3.9M
Net borrowing	$-32,000
Net cash flow	$7.8M
Net income	$13.7M
Operating cash flow minus SBC	$6.6M
Operating income	$13M
Revenue	$77.5M
Stock-based compensation	$688,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.38
Book value per share	$14.95
Debt / EBITDA	1.26
Debt / equity	0.4
Debt / FCF	2.8
Goodwill	$6.5M
Interest coverage	16
Long-term assets	$21.3M
Long-term liabilities	$13.9M
Net cash (debt)	$-9.1M
Net cash / market cap	-4.56%
Net debt / EBITDA	0.63
Net debt / equity	0.19
Net debt / FCF	1.35
Piotroski F-Score	5
Property, plant and equipment	$11.9M
Shareholders' equity	$47.6M
Tangible book value	$40.4M
Tangible book value per share	$12.69
Total assets	$74.5M
Total cash	$9.3M
Total debt	$18.9M
Total liabilities	$26.9M
WACC	4.39%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.14
Current assets	$53.2M
Current liabilities	$13M
Current ratio	4.1
Inventory turnover	2.44
Net working capital	$36M
Quick ratio	2.4
Working capital	$40.3M
Working capital turnover	2.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.31%
Dividend yield	0%
Shareholder yield	1.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	1,208.65%
10Y return CAGR	29.33%
10Y total return	1,208.65%
150-day SMA	$60.85
15Y price change	2,753.93%
15Y return CAGR	25.03%
15Y total return	2,753.93%
1D price change	1.77%
1M price change	-12.48%
1M total return	-12.48%
1W price change	5.76%
1W total return	5.76%
1Y price change	117.58%
1Y return CAGR	117.7%
1Y total return	117.58%
20-day SMA	$61.94
200-day SMA	$56.37
20Y price change	1,523.13%
20Y return CAGR	14.95%
20Y total return	1,523.11%
3M price change	9.7%
3M total return	9.7%
3Y price change	267.51%
3Y return CAGR	54.3%
3Y total return	267.51%
50-day SMA	$65.03
50-day SMA vs 200-day SMA	50over200
52-week high	$77.00
52-week high date	2026-09-04
52-week low	$28.50
52-week low date	2025-10-28
5Y price change	159.14%
5Y return CAGR	20.98%
5Y total return	159.14%
6M price change	20.89%
6M total return	20.89%
All-time high	$77.00
All-time high date	2026-09-04
All-time low	$0.81
All-time low date	2009-03-03
Average true range (ATR)	$2.63
Average volume	41.9K
Beta (1Y)	1.76
Beta (2Y)	0.44
Beta (5Y)	0.04
Change from 52-week high	-17.7%
Change from 52-week low	122.35%
Change from all-time high	-18.42%
Change from all-time low	7,657.81%
Change from open	0.57%
Day's gap	1.19%
Dollar volume	$2.8M
High price	$63.37
Low price	$63.01
Monthly RSI	61.53
Open price	$63.01
Position in 52-week range	100%
Premarket change	1.51%
Premarket close	$62.27
Premarket price	$63.21
Previous close	$62.27
Price vs 150-day SMA	3.24%
Price vs 20-day SMA	1.42%
Price vs 200-day SMA	11.44%
Price vs 50-day SMA	-3.41%
Relative volume	1.06
RSI	49.26
Sharpe ratio	1.56
Sharpe ratio (3Y)	0.93
Sharpe ratio (5Y)	0.55
Sortino ratio	2.75
Sortino ratio (3Y)	1.45
Sortino ratio (5Y)	0.9
Volume	44.4K
Weekly RSI	52.34
YTD price change	63.24%
YTD total return	63.24%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.5M
Float percentage	46.73%
Shares change (QoQ)	0.75%
Shares change (YoY)	-1.31%
Shares held by insiders	15.89%
Shares held by institutions	23.8%
Shares outstanding	3.2M
Short % of float	13.32%
Short % of shares	6.22%
Short ratio	2.5 days

Deeper analysis on PDEX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PDEX report

Is a complete PDEX research report available?

No complete published report is available for Pro-Dex, Inc. (PDEX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Pro-Dex, Inc. (PDEX)

Price

Financial snapshot

Fair-value bridge

Latest news · PDEX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PDEX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PDEX

Frequently asked questions